Literature DB >> 18452238

Human mesenchymal stem cells as a stable source of VEGF-producing cells.

Harumi Kagiwada1, Tetsuya Yashiki, Akira Ohshima, Mika Tadokoro, Noritoshi Nagaya, Hajime Ohgushi.   

Abstract

Vascular endothelial growth factor (VEGF) is a positive regulator and plays a crucial role in angiogenesis. We demonstrate that VEGF was highly expressed in cultures of human bone marrow-derived mesenchymal stem cells (hMSCs) and the high expression level was maintained during prolonged culture periods (checked up to passage 10). We also confirmed that in vivo hMSCs engrafted into immunodeficient mice could survive and secreted human VEGF. These findings suggest that implantation of hMSCs is a practical means as a source of VEGF production and might be effective in neoangiogenesis. Copyright (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18452238     DOI: 10.1002/term.79

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  23 in total

1.  Protective effects of ACLF sera on metabolic functions and proliferation of hepatocytes co-cultured with bone marrow MSCs in vitro.

Authors:  Xiao-Lei Shi; Jin-Yang Gu; Yue Zhang; Bing Han; Jiang-Qiang Xiao; Xian-Wen Yuan; Ning Zhang; Yi-Tao Ding
Journal:  World J Gastroenterol       Date:  2011-05-21       Impact factor: 5.742

Review 2.  Secretion of immunoregulatory cytokines by mesenchymal stem cells.

Authors:  Dobroslav Kyurkchiev; Ivan Bochev; Ekaterina Ivanova-Todorova; Milena Mourdjeva; Tsvetelina Oreshkova; Kalina Belemezova; Stanimir Kyurkchiev
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

Review 3.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part I: recapitulation of native tissue healing and variables for the design of delivery systems.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-02-19       Impact factor: 6.389

4.  Similarities Between Stem Cell Niches in Glioblastoma and Bone Marrow: Rays of Hope for Novel Treatment Strategies.

Authors:  Vashendriya V V Hira; Barbara Breznik; Miloš Vittori; Annique Loncq de Jong; Jernej Mlakar; Roelof-Jan Oostra; Mohammed Khurshed; Remco J Molenaar; Tamara Lah; Cornelis J F Van Noorden
Journal:  J Histochem Cytochem       Date:  2019-09-30       Impact factor: 2.479

5.  N-cadherin determines individual variations in the therapeutic efficacy of human umbilical cord blood-derived mesenchymal stem cells in a rat model of myocardial infarction.

Authors:  Eun Ju Lee; Eue-Keun Choi; Soo Kyoung Kang; Gi-Hwan Kim; Ju Young Park; Hyun-Jae Kang; Sae-Won Lee; Keum-Hyun Kim; Jin Sook Kwon; Ki Hong Lee; Youngkeun Ahn; Ho-Jae Lee; Hyun-Jai Cho; Soo Jin Choi; Won Il Oh; Young-Bae Park; Hyo-Soo Kim
Journal:  Mol Ther       Date:  2011-11-08       Impact factor: 11.454

6.  Engineered Fibrin Gels for Parallel Stimulation of Mesenchymal Stem Cell Proangiogenic and Osteogenic Potential.

Authors:  Kaitlin C Murphy; Marissa L Hughbanks; Bernard Y K Binder; Caroline B Vissers; J Kent Leach
Journal:  Ann Biomed Eng       Date:  2014-12-20       Impact factor: 3.934

7.  Hydrogels as a platform for stem cell delivery to the heart.

Authors:  Mazen Kurdi; Rony Chidiac; Caroline Hoemann; Fouad Zouein; Carlos Zgheib; Georgew W Booz
Journal:  Congest Heart Fail       Date:  2010 May-Jun

Review 8.  Vascular endothelial growth factor signaling in acute myeloid leukemia.

Authors:  Kim R Kampen; Arja Ter Elst; Eveline S J M de Bont
Journal:  Cell Mol Life Sci       Date:  2012-07-26       Impact factor: 9.261

Review 9.  Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke.

Authors:  Mark A Eckert; Quynh Vu; Kate Xie; Jingxia Yu; Wenbin Liao; Steven C Cramer; Weian Zhao
Journal:  J Cereb Blood Flow Metab       Date:  2013-06-12       Impact factor: 6.200

10.  Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells.

Authors:  Jaehyup Kim; Ryan A Denu; Bridget A Dollar; Leah E Escalante; Justin P Kuether; Natalie S Callander; Fotis Asimakopoulos; Peiman Hematti
Journal:  Br J Haematol       Date:  2012-05-15       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.